Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In dermatology research, double-blind clinical trials have demonstrated that GHK-Cu cream applied for 12 weeks produced a 70% improvement in skin laxity, 35% increase in procollagen synthesis, and measurable increases in dermal thickness (Finkley et al., 2005)
Peptides designed for subcutaneous delivery, which includes most clinically prescribed options such as BPC-157, CJC-1295/Ipamorelin, and GHK-Cu, are formulated for subcutaneous absorption rates
Last reviewed January 2019
Middle age is where the conditions these drugs treat, obesity and type 2 diabetes, become common, and where most people still have private insurance or the income to cover a drug that has listed at more than $1,000 a month
FDA (Center for Drug Evaluation and Research) issued a Drug Development Tool Letter of Support (DDT-BMQ-000157) to the Critical Path for Parkinsons (CPP) consortium, encouraging further studies and use of Syn-SAAs in human CSF to improve the efficiency of early-intervention clinical trials for neurodegenerative diseases defined by a shared synuclein biology [26]
Dual Sourcing for Critical Inputs Primary + secondary qualified suppliers for: Reduced L-Glutathione (GSH) Phospholipid / liposomal carrier systems Stabilization co-antioxidants (ascorbate / ALA systems, as used) Cross-validation of specs and assay consistency / geographic diversification for logistics/geopolitical buffering Approved Vendor List (AVL) Discipline Pre-qualification audits / spec alignment / ongoing quality/delivery/consistency scoring / periodic re-audit Only AVL-cleared suppliers enter production
